SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0000950170-23-047496 from Comera Life Sciences Holdings, Inc. (CMRA) (CIK 0001907685)

Comera Life Sciences Holdings, Inc. (CMRA) (CIK 0001907685)
Date: Sept. 11, 2023 · CIK: 0001907685 · Accession: 0000950170-23-047496

AI Filing Summary & Sentiment

File numbers found in text: 333-274253

Date
September 11, 2023
Author
Not clearly detected
Form
CORRESP
Company
Comera Life Sciences Holdings, Inc. (CMRA) (CIK 0001907685)

Letter

Comera Life Sciences Holdings, Inc.

12 Gill Street, Suite 4650

Woburn, Massachusetts 01801

September 11, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Comera Life Sciences Holdings, Inc.

Registration Statement on Form S-3

File No. 333-274253

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Comera Life Sciences Holdings, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-274253) so that it may become effective at 4:00 p.m. Eastern time on September 13, 2023, or as soon thereafter as practicable.

[Remainder of this page intentionally left blank]

Very truly yours,
Comera Life Sciences Holdings, Inc.

Show Raw Text
CORRESP
1
filename1.htm

  CORRESP

Comera Life Sciences Holdings, Inc.

  12 Gill Street, Suite 4650

  Woburn, Massachusetts 01801

  September 11, 2023

  VIA EDGAR

  Securities and Exchange Commission

  Division of Corporation Finance

  100 F Street, N.E.

  Washington, D.C. 20549

  	Re:	Comera Life Sciences Holdings, Inc.

  Registration Statement on Form S-3

  File No. 333-274253

  Request for Acceleration

  Ladies and Gentlemen:

  	Pursuant to Rule 461 under the Securities Act of 1933, as amended, Comera Life Sciences Holdings, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-274253) so that it may become effective at 4:00 p.m. Eastern time on September 13, 2023, or as soon thereafter as practicable.

  [Remainder of this page intentionally left blank]

    Very truly yours,

    Comera Life Sciences Holdings, Inc.

    By:

    /s/ Jeffrey S. Hackman

    Name:

    Jeffrey S. Hackman

    Title:

    Chairman, President and CEO